Amgen / Acknowledgements Major Sponsors Partners Sommaire Partners / /
Country
Netherlands / United States / United Kingdom / /
Facility
University Paris Dauphine / Chapel Hill USA / /
IndustryTerm
treatment of cancers / treatment of severe diseases / silico tools / cancer treatment / carrier-mediated anticancer agents / imaging / Treatment of Cancer / /
MedicalCondition
tatic melanoma / ovarian cancer / colorectal cancer / universal cancer / pancreatic tumors / melanoma / metastatic breast cancer / Tumor pH / freshly explanted tumors / Breast Cancer / pancreatic cancer / glioblastoma / colon tumors / cancers / Tumor / cancer / NSCLC / lysosome cancer / sarcoma / lung cancer / bone marrow rhabdomyosarcoma / diseases / Chronic Myeloid Leukemia / her2-positive breast cancer / human pancreatic tumors / acute myeloid leukemia / /
Local Organising Committee / European Organization for Treatment of Cancer / Lyon FR / Marseille FR / Paris FR / /
Person
Nikolai Tupitsyn / Olivier Adotevi / Régis Costello / J. Ciccolini / Antonello DiPaolo / Jennifer Bonner / Hillary Calvert London / Philipp Tsvetkov / Marc Ychou Montpellier / Marion Peyressatre / Patrick Couvreur / Annette Larsen / Charles Skarbek / David Planchard / Eddy Pasquier / Duncan Jodrell / Sebastien Benzekry / G. Milano / Claude Le Pen / David Cox / Christophe Chassagnole / Simona Mura / François Devred / Paul Mesange / Gerard Milano / William Zamboni / Norbert Lutz / Chantal Csajka / Wolfgang Walther / A. Larsen / Van Hasselt Leiden / Nicolas André / Sergei Zakharov Moscow / Thierry Bastogne / Damien Reita / Howard Mc Leod / Markus Joerger St Gallen / M.C. Etienne-Grimaldi / Maria Rivera Berlin / Jean-Pierre Benoit / Daniel Lafitte / Adriana Albini Milano / /
Position
Pr PM Martin / Director Biosimilars Global Medical / Chair / /
Product
ifosfamide / fluorouracil / /
Technology
Biosensors / Drug Delivery / Drug Discovery / chemotherapy / simulation / Drug development / /